Final Prototype Refinement of Adaptive Cell Phone Support

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15-20
SponsorChildren's Hospital Los Angeles

About this trial

The goal of this feasibility pilot trial is to finalize the design of a mobile health intervention for promoting medication adherence in a population of adolescents and young adults with chronic health conditions. The main question\[s\] it aims to answer are:

1. Is the final version of the intervention sufficiently feasible, usable, and acceptable for evaluation in a randomized clinical trial? 2. Do participants show improvements in medication adherence during their field testing of the intervention?

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Children's Hospital Los Angeles patient

between 15-20 years old at enrollment

taking at least one oral medication per day for a chronic health condition

English speaking

Disqualifiers

None

Trial design

Design model

Single group

Treatments tested in this trial

  • Adaptive Cell Phone Support

    Behavioral

    Mobile health adherence promotion based on the supportive accountability model

Treatment groups

35 Participants
are divided into 1 treatment group
Group A: Adaptive Cell Phone SupportExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Total scores on the theoretical framework of acceptability questionnaire

Higher scores indicate a greater "extent to which people delivering or receiving a healthcare intervention consider it to be appropriate, based on anticipated or experienced cognitive and emotional responses to the intervention"; the minimum value of this questionnaire is 7 and the maximum value is 35.

Time frame
Baseline to 3 weeks
2

Mean scores on the Mobile Health App Usability Questionnaire

Higher scores indicate greater ease with which users can use technology to achieve a particular goal; the minimum value of this questionnaire is 1 and the maximum value is 7.

Time frame
Baseline to 3 weeks
3

Total scores on the Visual Analogue Scale

Percentage of doses taken our of 100%; higher numbers indicate greater medication adherence. This scale presents participants with a line, marked 0 on the left and 100 on the right, and participants can drag a marker to the place on the line that best visually indicated their adherence.

Time frame
Baseline to 3 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Children's Hospital Los Angeles

Lead sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator